Prostate Cancer: New Treatments & Personalized Care Improve Outlook

• Prostate cancer is a common male cancer; early detection is vital as initial stages are often asymptomatic, mimicking benign prostatic hyperplasia (BPH) symptoms.
• Diagnosis involves digital rectal examination (DRE), PSA blood tests, multiparametric MRI (PIRADS score), and biopsies (Gleason grade) to assess cancer presence and aggressiveness.
• Staging, typically via PSMA PET-CT, classifies the cancer as localized, locally advanced, nodal, or metastatic, which guides personalized treatment strategies.
• Advanced treatment options include Robotic-Assisted Radical Prostatectomy, Robotic Radiosurgery (CyberKnife SBRT), Radioligand Therapy, and PARP Inhibitors.
• The field is advancing towards personalized medicine, tailoring therapies to each patient's unique disease profile for improved outcomes and quality of life.

Why It Matters: New treatments offer personalized care, improving prostate cancer outcomes and quality of life.